dartreg
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02244801)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dartreg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02474199 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | Clinical Trials in Organ Transplantation in Children, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco |
| NCT02188719 | Phase 1 | Dec 1, 2014 | National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Francisco |
| NCT02244801 | Phase 1 | Nov 1, 2014 | University of California, San Francisco |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of California, San Francisco | Academic/Hospital | 3 | 1 | 2 | 2014 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 2 | 2014 |
| Clinical Trials in Organ Transplantation in Children | Government | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1